Detection of Minimal Residual Disease in Patients with Multiple Myeloma by PCR-Based IGH Gene Clonality Analysis Using DNA Extracted From Archival Bone Marrow Slides

被引：0
|
作者：
Takamatsu, Hiroyuki [1 ]
Ogawa, Yoshiyasu [2 ]
Kobayashi, Noriko [2 ]
Obata, Kazue [2 ]
Narisawa, Tadashi [2 ]
Nakayama, Kouji [2 ]
Nakao, Shinji [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
[2] Mitsubishi Chem Medience Corp, Adv Med Sci Res Ctr, Tokyo, Japan
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：820 / 821
页数：2
相关论文
共 50 条
  • [21] B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma Patients
    Mendonca de Pontes, Roberia
    Flores-Montero, Juan
    Sanoja-Flores, Luzalba
    Puig, Noemi
    Pessoa de Magalhaes, Roberto J.
    Corral-Mateos, Alba
    Salgado, Anna Beatriz
    Garcia-Sanchez, Omar
    Perez-Moran, Jose
    Mateos, Maria-Victoria
    Burgos, Leire
    Paiva, Bruno
    te Marvelde, Jeroen
    van der Velden, Vincent H. J.
    Aguilar, Carlos
    Barez, Abelardo
    Garcia-Mateo, Aranzazu
    Labrador, Jorge
    Leoz, Pilar
    Aguilera-Sanz, Carmen
    Durie, Brian
    van Dongen, Jacques J. M.
    Maiolino, Angelo
    Sobral da Costa, Elaine
    Orfao, Alberto
    CANCERS, 2021, 13 (07)
  • [22] Optimum Diagnostic Methods for Monitoring Minimal Residual Disease in Bone Marrow Biopsies Collected From Myeloma Patients
    Griffith, Megan P.
    Linden, Michael A.
    McKenna, Robert W.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (03) : 470 - 471
  • [23] Monitoring of minimal residual disease in multiple myeloma after allogeneic stem cell transplantation:: flow cytometry versus PCR-based techniques
    Lioznov, MV
    Cortes-Dericks, L
    Schwartz, S
    Badbaran, A
    Fehse, B
    Zander, AR
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S145 - S146
  • [24] Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas
    Brinckmann, R
    Kaufmann, O
    Reinartz, B
    Dietel, M
    JOURNAL OF PATHOLOGY, 2000, 190 (01): : 55 - 60
  • [25] V(D)J Sequence Capture for DNA-Based Minimal Residual Disease Detection in Multiple Myeloma
    Rustad, Even H.
    Hultcrantz, Malin
    Yellapantula, Venkata D.
    Akhlaghi, Theresia
    Ho, Caleb
    Arcila, Maria E.
    Roshal, Mikhail
    Patel, Akshar
    Devlin, Sean M.
    Jacobsen, Austin
    Huang, Ying
    Miller, Jeffrey E.
    Papaemmanuil, Elli
    Landgren, Ola
    BLOOD, 2018, 132
  • [26] IGH and IGK Rearrangement and IGH Somatic Hypermutation Analysis Using Next-generation Sequencing for the Detection of Clonality in High-risk Korean Multiple Myeloma Patients
    Kim, Miyoung
    Kim, Hyo Jung
    Lee, Young Kyung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E68 - E69
  • [27] Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma
    Martinez-Lopez, Joaquin
    Martinez-Sanchez, Pilar
    Garcia-Sanz, Ramon
    Sarasquete, Maria Eugenia
    Ayala, Rosa
    Gonzalez, Marcos
    Bautista, Jose Manuel
    Gonzalez, David
    San Miguel, Jesus
    Garcia-Effron, Guillermo
    Lahuerta, Juan Jose
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (03): : 364 - 370
  • [28] Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow
    Langerhorst, Pieter
    Noori, Somayya
    Zajec, Marina
    De Rijke, Yolanda B.
    Gloerich, Jolein
    van Gool, Alain J.
    Caillon, Helene
    Joosten, Irma
    Luider, Theo M.
    Corre, Jill
    VanDuijn, Martijn M.
    Dejoie, Thomas
    Jacobs, Joannes F. M.
    CLINICAL CHEMISTRY, 2021, 67 (12) : 1689 - 1698
  • [29] Detection of minimal residual disease in the bone marrow of breast cancer patients using multiplex gene expression measurements with the Nanostring nCounter Assay
    Mudalagiriyappa, Chidananda
    Watson, Mark A.
    Pillai, Sreeraj G.
    Fleming, Timothy R.
    Aft, Rebecca L.
    CANCER RESEARCH, 2011, 71
  • [30] Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma
    Agnieszka Blum
    Katy Haussmann
    Mathias Streitz
    Stephan Schlickeiser
    Carola Tietze-Buerger
    Igor Wolfgang Blau
    Lutz Uharek
    Scientific Reports, 9
12345